Search Results - "Vernacotola, L."

Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice by Fagiolini, A., Aguglia, E., Ballerini, A., Callista, G., Carpiniello, B., Clerici, M., Corrivetti, G., De Fazio, P., De Filippis, S., De Giorgi, S., Favaretto, G., Ferri, E., Gargiulo, G., Giustra, M.G., La Barbera, D., Maina, G., Mencacci, C., Montagnani, G., Panariello, A., Pigato, G., Tortorella, A., Vernacotola, L., Vita, A.

“…•Treatment persistence refers to the act of continuing a medication over time and may be an indirect measure of efficacy and tolerability.•A relatively high…”
Get full text

PMH19 HEALTH CARE COSTS RELATED TO SCHIZOPHRENIA IN PATIENTS INITIATING ARIPIPRAZOLE LONG-ACTING INJECTABLE (LAI): RESULTS FROM THE DOMINO STUDY by Marcellusi, A., Bini, C., Rossi, D., Reggiardo, G., Giustra, M.G., Montagnani, G., Vernacotola, L., Fagiolini, A., Mennini, F.S.

Get full text

Randomized trial to evaluate cardiometabolic and endothelial function in patients with plasma HIV-1 RNA suppression switching to darunavir/ritonavir with or without nucleoside analogues by Guaraldi, G, Zona, S, Cossarizza, A, Vernacotola, L, Carli, F, Lattanzi, A, Beghetto, B, Orlando, G, De Biasi, S, Termini, R, Garau, M

“…We performed a study to evaluate change in cardiometabolic and endothelial function in HIV-infected patients switching to darunavir/ritonavir (DRV/r)…”
Get more information